How to Get Soolantra Online in Bilbao
Looking to treat rosacea in Bilbao? Learn how EU-licensed doctors review your case online for a 40 € fee, issuing a REMPE prescription within 24 hours when clinically appropriate.

DIRECT ANSWER
An online consultation lets an EU-licensed doctor review your case and, if appropriate, issue a prescription that is valid across the EU.
Less than 4 hours on average
Prescription issued in less than 4 hours on average if approved.
EU-licensed doctors
Every case is reviewed by a licensed clinician.
Valid across the EU
Approved prescriptions can be used at any EU pharmacy.
In this article
Looking to treat inflammatory rosacea with Soolantra online in Bilbao? Patients in Bilbao can access clinical care through Hi-Doctor's digital platform without waiting weeks for an in-person appointment. While brand-name Soolantra consists of standalone ivermectin 1% cream, our EU-licensed doctors evaluate your symptoms to determine whether targeted topical therapy—such as a compounded gel combining ivermectin 1%, metronidazole 0.75%, and niacinamide 2%, or azelaic acid 15% gel—is clinically appropriate for your skin. The 40 € one-off consultation is reviewed within 24 hours, and approved REMPE prescriptions can be presented at any EU pharmacy.
How it works — get your consultation in 4 steps
Accessing medical evaluation for rosacea is completed entirely online through a secure, asynchronous process:
- Complete the medical questionnaire: Answer focused clinical questions about your skin symptoms, medical history, and past treatments. You will be prompted to upload clear photographs of the affected areas of your face for the doctor to grade severity.
- Submit your consultation: Pay the 40 € one-off consultation fee through our secure checkout.
- Doctor evaluation: An EU-licensed doctor reviews your answers and photos asynchronously within 24 hours. If treatment is not clinically appropriate, the 40 EUR consultation fee is refunded in full if the doctor does not issue a prescription.
- Receive your REMPE prescription: If approved, your official digital prescription (REMPE) is immediately available in your patient portal as a downloadable PDF and sent via email notification.

Who qualifies
Online consultations are designed for adults experiencing mild to moderate papulopustular rosacea or persistent central facial erythema. To qualify for prescription consideration, patients must meet specific clinical criteria:

- Eligible conditions: Adults with visible inflammatory lesions (papules and pustules), redness across the cheeks, nose, or forehead, and suspected Demodex-associated inflammation.
- Photo verification: You must provide well-lit facial photographs during the questionnaire stage so the doctor can assess lesion morphology.
- Exclusions and referrals: Hi-Doctor provides topical treatments only. Patients presenting with ocular rosacea (eye pain, gritty sensation, eyelid inflammation), rhinophyma (tissue thickening of the nose), severe cystic lesions, or scarring are referred to in-person care. Oral medications like isotretinoin or oral antibiotics are not prescribed through this service.
What Soolantra actually does
Soolantra contains ivermectin 1%, an active agent that provides dual anti-inflammatory and antiparasitic activity. It targets Demodex folliculorum mites, which reside in hair follicles and are found in significantly higher densities on the skin of rosacea patients. By reducing mite overgrowth and inhibiting inflammatory cytokine pathways, ivermectin reduces papules, pustules, and associated swelling.
Hi-Doctor's prescribing doctors do not prescribe standalone brand Soolantra. Instead, when clinically appropriate, doctors prescribe a compounded papulopustular rosacea gel featuring ivermectin 1% paired with metronidazole 0.75% and niacinamide 2%. Metronidazole adds complementary antimicrobial and anti-redness action, while niacinamide calms the skin barrier. For erythema-dominant cases, a compounded cream containing metronidazole 0.75%, niacinamide 4%, micronised azelaic acid 10%, and allantoin 0.5% or standalone azelaic acid 15% gel may be selected.
Rosacea is a chronic condition that is managed rather than permanently cured. Visible improvement typically appears between weeks 4 and 8, with full therapeutic assessment conducted at 12 weeks. Long-term maintenance and managing common triggers—such as UV exposure, heat, alcohol, spicy foods, and emotional stress—remain essential to prevent relapse.
Side effects and when to stop
Topical rosacea treatments are generally well tolerated, but mild, transient skin reactions can occur during the first few weeks of application:
- Common reactions: Mild burning or stinging sensations, localized skin dryness, itching, and temporary increases in redness.
- Management: Using a gentle, fragrance-free moisturizer alongside the treatment helps offset dryness.
- When to discontinue: Stop application immediately and seek medical attention if you experience severe contact dermatitis, facial swelling, hives, or signs of an allergic reaction.
Why Hi-Doctor vs. walking into a clinic
Managing rosacea in Bilbao through traditional routes often involves long waiting lists for private dermatology visits or public healthcare delays. Hi-Doctor offers a streamlined, fully auditable digital alternative.

Over 50,000 patients served across Europe with a 4.8/5 Trustpilot rating for private digital consultations.
| Feature | Hi-Doctor Online Consultation | Traditional In-Person Clinic |
|---|---|---|
| Review turnaround | Doctor reviews within 24 hours | Days to weeks for an appointment |
| Consultation fee | 40 € flat one-off fee | 80 € to 150 €+ per visit |
| Prescription standard | Official REMPE PDF with validation QR | Paper or regional electronic prescription |
| Refund policy | Fee refunded in full if no prescription is issued | Non-refundable clinic visit fee |
| Format | 100% online questionnaire with photo upload | In-person waiting room visit |
COMMON QUESTIONS
Frequently asked questions
Under Directive 2011/24/EU on cross-border healthcare, a prescription issued in Spain can be presented at any EU pharmacy. The REMPE PDF contains all prescriber and patient data required by Commission Implementing Directive 2012/52/EU. In Spain, pharmacists validate the code via the official central registry. In other EU Member States, the pharmacist reviews the document and may dispense a locally marketed equivalent containing the prescribed active ingredients. Dispensing is subject to national rules, and pharmacists retain the right to refuse.





